0 CHECKOUT

PRODUCT FILTERS

REGION

9,772
5,821
5,678
5,002
4,925

COUNTRY

4,478
1,030
315
279
254

CATEGORIES

  • 1,111
  • 123
    • 45
    • 368
    • 47
  • 179
  • 807
  • 499
  • 832
  • 220
  • 50
  • 60
  • 888
  • 1,529
  • 77
  • 14
  • 503
  • 1,458
  • 2,472
    • 73
    • 124
    • 59
    • 54
    • 35
    • 33
    • 10
    • 10
    • 11
    • 14
  • 23
  • 267
  • 28
  • 2,826
  • 1,048
  • 259
SHOW ALL

PRICE

2,698
8,635
22,605
33,170

PUBLISHED

6,670
8,106
14,586
33,170

PRODUCT TYPE

30,086
1,314
1,258
162
84
68
54
42
35
21
17
15
6
4
3
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

33,170 Products

MSL-KOL Engagement: Optimal Reach and Response Under New Rules

Delivering optimal MSL performance in terms of building strong KOL relationships remains a formidable challenge as regulations and compliance requirements continue to evolve across the US and Europe....

Published:  July 2015
Price:  From

Biological Product (except Diagnostic) Manufacturing Industry in the U.S. and its International Trade [2015 Q3 Edition]

This 2015 publication of Biological Product (except Diagnostic) Manufacturing Industry report is the comprehensive market research guide for the industry. It contains the latest information on the...

Published:  July 2015
Price:  From

Pharmaceutical Manufacturing

Brief Excerpt from Industry Overview Chapter: Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson,...

Published:  July 2015
Price: 

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil

The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the country’s healthcare market...

Published:  July 2015
Price:  From

Global Alzheimer’s Disease Drugs Market & Pipeline Drugs Market Analysis to 2020

Alzheimer’s disease is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global...

Published:  July 2015
Price:  From

Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis

The Competitive Intelligence report Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis describes product portfolios and R&D pipelines of granulocyte colony...

Published:  July 2015
Price:  From

Active Pharmaceutical Ingredients Global Market Analysis – Forecast (2014-2020

This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique...

Published:  July 2015
Price:  From

Image-Guided Neurosurgery

Image-Guided Neurosurgery provides readers with an update on the revolutionary improvements in imaging and visualization relating to neurosurgery. From the development of the pneumoencephalogram, to...

Published:  July 2015
Price: 

Vital Signs - The Analyst's Perspective - June 2015 Issue

This issue of Vital Signs, released in July 2015, discusses Affmetrix's acquisition of Eureka Genomics, OPKO Health's acquisition of Bio-Reference Laboratories, CVS Health's acquisition of Target's...

Published:  July 2015
Price:  From

Investigation Report on China's Glipizide Market, 2010-2019

According to the statistics of the International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382...

Published:  July 2015
Price:  From

Investigation Report on China's Sorafenib Market, 2010-2019

The incidence of liver cancer and kidney cancer in China grew gradually over time. According to the Guidelines for the Kidney Cancer Diagnosis and Treatment in China (the 2013 version), kidney cancer...

Published:  July 2015
Price:  From

Investigation Report on China's Gliquidone Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

Published:  July 2015
Price:  From

Investigation Report on China's Gliquidone Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

Published:  July 2015
Price:  From

Investigation Report on China's Glipizide Market, 2010-2019

According to the statistics of the International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382...

Published:  July 2015
Price:  From

Investigation Report on China's Sorafenib Market, 2010-2019

The incidence of liver cancer and kidney cancer in China grew gradually over time. According to the Guidelines for the Kidney Cancer Diagnosis and Treatment in China (the 2013 version), kidney cancer...

Published:  July 2015
Price:  From

Venezuela Pharmaceuticals and Healthcare Report Q3 2015

The Venezuelan governments remaining protection of its domestic pharmaceutical and healthcare industries will hamper investor sentiment as the country remains critically reliant on foreign medicine...

Published:  July 2015
Price: 

Egypt Pharmaceuticals and Healthcare Report Q3 2015

The positive outlook for Egypt's pharmaceutical market has been reinforced, with access to medicines increasing through enhancing health insurance uptake and a greater interest among foreign pharmaceutical...

Published:  July 2015
Price: 

South Africa Pharmaceuticals and Healthcare Report Q3 2015

Improvements to South Africa's pharmaceutical supply chain will result in fewer drug shortages, making the country a more attractive destination for local manufacturing. Inequalities will still persist...

Published:  July 2015
Price: 

Iraq Pharmaceuticals and Healthcare Report Q3 2015

Iraq's pharmaceutical market will remain an unattractive proposition for multinational drugmakers in the short-term at least. Lower oil prices and the presence of Islamic State will subdue government...

Published:  July 2015
Price: 

Cambodia and Laos Pharmaceuticals and Healthcare Report Q3 2015

Despite improvements to the healthcare sector, high out of pocket expenditure means that access to healthcare will remain a challenging issue in Cambodia. Further investments in the sector will boost...

Published:  July 2015
Price: 
Loading Indicator

Our Clients